Syndicated Report

InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 4

May 3, 2021

Given the ongoing roll-out of the COVID-19 vaccine across the US, InCrowd conducted its fourth wave of research on perceptions and observations of infectious disease experts on the COVID-19 vaccine to gauge progress and further predictions. This report compares recent findings on efficacy, impact, and recommendations related to the COVID-19 vaccine with data from earlier in the year.*

* Please note, views in this survey reflect opinions only as reported by responding physicians.


  • Method:
    • 10-Minute MicroSurvey via InCrowd
  • Crowds:
    • Infectious disease doctors (n=101)
    • Other Specialists (n=300)
  • Screening Criteria:
    • Physicians identifying as at least somewhat familiar with vaccines in development for COVID-19
  • Fielding Period:
    • Mar 1st – 3rd, 2021

  • This field is for validation purposes and should be left unchanged.